{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:25:20Z","timestamp":1790288720509,"version":"4.1.0"},"reference-count":221,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"am","delay-in-days":324,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016239","name":"University of Occupational and Environmental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016239","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.bcp.2023.115663","type":"journal-article","created":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T19:20:25Z","timestamp":1687029625000},"page":"115663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Promising small molecule anti-fibrotic agents: Newly developed or repositioned drugs targeting myofibroblast transdifferentiation"],"prefix":"10.1016","volume":"214","author":[{"given":"Shin","family":"Ishikane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Arioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1960-8268","authenticated-orcid":false,"given":"Fumi","family":"Takahashi-Yanaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.bcp.2023.115663_b0005","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41584-019-0322-7","article-title":"Shared and distinct mechanisms of fibrosis","volume":"15","author":"Distler","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"issue":"7835","key":"10.1016\/j.bcp.2023.115663_b0010","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bcp.2023.115663_b0015","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bcp.2023.115663_b0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.bcp.2023.115663_b0025","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/CIRCRESAHA.120.316958","article-title":"Myofibroblasts and Fibrosis: Mitochondrial and Metabolic Control of Cellular Differentiation","volume":"127","author":"Gibb","year":"2020","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.bcp.2023.115663_b0030","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/wrr.12942","article-title":"The myofibroblast and Giulio Gabbiani: An inseparable couple celebrates their 50 years golden wedding anniversary","volume":"29","author":"Desmouliere","year":"2021","journal-title":"Wound Repair Regen."},{"issue":"13","key":"10.1016\/j.bcp.2023.115663_b0035","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.227900","article-title":"The myofibroblast at a glance","volume":"133","author":"Pakshir","year":"2020","journal-title":"J. Cell Sci."},{"issue":"1","key":"10.1016\/j.bcp.2023.115663_b0040","first-page":"56","article-title":"Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar","volume":"146","author":"Desmouliere","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcp.2023.115663_b0045","doi-asserted-by":"crossref","unstructured":"Jun, J.I. and L.F. Lau, Resolution of organ fibrosis. J Clin Invest, 2018. 128(1): p. 97-107.","DOI":"10.1172\/JCI93563"},{"issue":"1","key":"10.1016\/j.bcp.2023.115663_b0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41584-019-0324-5","article-title":"Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases","volume":"16","author":"Hinz","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bcp.2023.115663_b0055","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mam.2018.06.003","article-title":"Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications","volume":"65","author":"Weiskirchen","year":"2019","journal-title":"Mol. Aspects Med."},{"issue":"5","key":"10.1016\/j.bcp.2023.115663_b0060","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/BF02147594","article-title":"Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction","volume":"27","author":"Gabbiani","year":"1971","journal-title":"Experientia"},{"key":"10.1016\/j.bcp.2023.115663_b0065","first-page":"115","article-title":"Isolation and phenotypic characterization of lung fibroblasts","volume":"117","author":"Baglole","year":"2005","journal-title":"Methods Mol. Med."},{"issue":"12","key":"10.1016\/j.bcp.2023.115663_b0070","doi-asserted-by":"crossref","first-page":"9099","DOI":"10.1002\/jcp.26860","article-title":"Fibroblasts and mesenchymal stem cells: Two sides of the same coin?","volume":"233","author":"Soundararajan","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"7","key":"10.1016\/j.bcp.2023.115663_b0075","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1172\/JCI74783","article-title":"Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis","volume":"124","author":"Moore-Morris","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2023.115663_b0080","doi-asserted-by":"crossref","first-page":"12260","DOI":"10.1038\/ncomms12260","article-title":"Genetic lineage tracing defines myofibroblast origin and function in the injured heart","volume":"7","author":"Kanisicak","year":"2016","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bcp.2023.115663_b0085","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/cvr\/cvu062","article-title":"Crosstalk between fibroblasts and inflammatory cells","volume":"102","author":"Van Linthout","year":"2014","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.bcp.2023.115663_b0090","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cardiores.2006.10.002","article-title":"The role of TGF-beta signaling in myocardial infarction and cardiac remodeling","volume":"74","author":"Bujak","year":"2007","journal-title":"Cardiovasc. Res."},{"issue":"8","key":"10.1016\/j.bcp.2023.115663_b0095","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/jcmm.13085","article-title":"Activation of Wnt\/\u03b2-catenin signalling is required for TGF-\u03b2\/Smad2\/3 signalling during myofibroblast proliferation","volume":"21","author":"Xu","year":"2017","journal-title":"J. Cell Mol. Med."},{"issue":"13","key":"10.1016\/j.bcp.2023.115663_b0100","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1089\/ars.2013.5793","article-title":"The lung alveolar lipofibroblast: an evolutionary strategy against neonatal hyperoxic lung injury","volume":"21","author":"Rehan","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2023.115663_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.645400","article-title":"FGF10 and Lipofibroblasts in Lung Homeostasis and Disease: Insights Gained From the Adipocytes","volume":"9","author":"Lv","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115663_b0110","doi-asserted-by":"crossref","first-page":"L869","DOI":"10.1152\/ajplung.00109.2019","article-title":"The lipofibroblast: more than a lipid-storage depot","volume":"316","author":"McGowan","year":"2019","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115663_b0115","first-page":"213","article-title":"Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis","volume":"119","author":"Kim","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bcp.2023.115663_b0120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40139-017-0134-x","article-title":"Heterogeneity of Fibroblasts and Myofibroblasts in Pulmonary Fibrosis","volume":"5","author":"Habiel","year":"2017","journal-title":"Curr Pathobiol Rep"},{"issue":"52","key":"10.1016\/j.bcp.2023.115663_b0125","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1117988108","article-title":"Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition","volume":"108","author":"Rock","year":"2011","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.bcp.2023.115663_b0130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1385\/CBB:38:3:239","article-title":"Hyperoxia augments pulmonary lipofibroblast-to-myofibroblast transdifferentiation","volume":"38","author":"Rehan","year":"2003","journal-title":"Cell Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.bcp.2023.115663_b0135","doi-asserted-by":"crossref","first-page":"L667","DOI":"10.1152\/ajplung.00358.2004","article-title":"Mechanism of nicotine-induced pulmonary fibroblast transdifferentiation","volume":"289","author":"Rehan","year":"2005","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115663_b0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.stem.2016.10.004","article-title":"Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis","volume":"20","author":"El Agha","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"10","key":"10.1016\/j.bcp.2023.115663_b0145","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.3390\/cells9102321","article-title":"Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?","volume":"9","author":"Claveria-Cabello","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2023.115663_b0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2023.115663_b0155","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF03403533","article-title":"Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair","volume":"1","author":"Bucala","year":"1994","journal-title":"Mol. Med."},{"issue":"4","key":"10.1016\/j.bcp.2023.115663_b0160","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s004180050235","article-title":"Platelet-derived growth factor-B induces transformation of fibrocytes into spindle-shaped myofibroblasts in vivo","volume":"109","author":"Oh","year":"1998","journal-title":"Histochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115663_b0165","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1167\/iovs.62.4.8","article-title":"Interleukin-1 and Transforming Growth Factor Beta: Commonly Opposing, but Sometimes Supporting, Master Regulators of the Corneal Wound Healing Response to Injury","volume":"62","author":"Wilson","year":"2021","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bcp.2023.115663_b0170","doi-asserted-by":"crossref","unstructured":"Abe, R., et al., Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol, 2001. 166(12): p. 7556-62.","DOI":"10.4049\/jimmunol.166.12.7556"},{"issue":"5","key":"10.1016\/j.bcp.2023.115663_b0175","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav7384","article-title":"Differentiated fibrocytes assume a functional mesenchymal phenotype with regenerative potential","volume":"5","author":"Ling","year":"2019","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.bcp.2023.115663_b0180","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00011-020-01330-4","article-title":"IL-18\/IL-18R1 promotes circulating fibrocyte differentiation in the aging population","volume":"69","author":"Niu","year":"2020","journal-title":"Inflamm. Res."},{"issue":"3","key":"10.1016\/j.bcp.2023.115663_b0185","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1164\/rccm.201301-0132OC","article-title":"The endothelin A receptor mediates fibrocyte differentiation in chronic obstructive asthma. The involvement of connective tissue growth factor","volume":"188","author":"Weng","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.bcp.2023.115663_b0190","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00428-001-0551-3","article-title":"CD34+ fibrocytes in neoplastic and inflammatory pancreatic lesions","volume":"440","author":"Barth","year":"2002","journal-title":"Virchows Arch."},{"issue":"1","key":"10.1016\/j.bcp.2023.115663_b0195","first-page":"59","article-title":"The distribution and role of myofibroblasts and CD34-positive stromal cells in normal pancreas and various pancreatic lesions","volume":"19","author":"Kuroda","year":"2004","journal-title":"Histol. Histopathol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115663_b0200","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00428-006-0347-6","article-title":"CD34+ fibrocytes in chronic cystitis and noninvasive and invasive urothelial carcinomas of the urinary bladder","volume":"450","author":"Nimphius","year":"2007","journal-title":"Virchows Arch."},{"key":"10.1016\/j.bcp.2023.115663_b0205","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.actbio.2021.03.038","article-title":"Macrophage phenotypes in tissue repair and the foreign body response: Implications for biomaterial-based regenerative medicine strategies","volume":"133","author":"Martin","year":"2021","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.bcp.2023.115663_b0210","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev-physiol-022516-034356","article-title":"Mechanisms of Organ Injury and Repair by Macrophages","volume":"79","author":"Vannella","year":"2017","journal-title":"Annu. Rev. Physiol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115663_b0215","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41581-019-0110-2","article-title":"Macrophages: versatile players in renal inflammation and fibrosis","volume":"15","author":"Tang","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"issue":"12","key":"10.1016\/j.bcp.2023.115663_b0220","doi-asserted-by":"crossref","first-page":"e2495","DOI":"10.1038\/cddis.2016.402","article-title":"Inflammatory macrophages can transdifferentiate into myofibroblasts during renal fibrosis","volume":"7","author":"Meng","year":"2016","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.bcp.2023.115663_b0225","doi-asserted-by":"crossref","first-page":"8809","DOI":"10.18632\/oncotarget.6604","article-title":"TGF-\u03b2\/Smad3 signalling regulates the transition of bone marrow-derived macrophages into myofibroblasts during tissue fibrosis","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.bcp.2023.115663_b0230","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1681\/ASN.2016050573","article-title":"Macrophage-to-Myofibroblast Transition Contributes to Interstitial Fibrosis in Chronic Renal Allograft Injury","volume":"28","author":"Wang","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bcp.2023.115663_b0235","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1326-5-32","article-title":"Pericyte-specific expression of PDGF beta receptor in mouse models with normal and deficient PDGF beta receptor signaling","volume":"5","author":"Winkler","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bcp.2023.115663_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109869","article-title":"Diverse origins and activation of fibroblasts in cardiac fibrosis","volume":"78","author":"Aujla","year":"2021","journal-title":"Cell. Signal."},{"issue":"11","key":"10.1016\/j.bcp.2023.115663_b0245","doi-asserted-by":"crossref","first-page":"C1098","DOI":"10.1152\/ajpcell.00171.2013","article-title":"Type-1 pericytes participate in fibrous tissue deposition in aged skeletal muscle","volume":"305","author":"Birbrair","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"6","key":"10.1016\/j.bcp.2023.115663_b0250","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/01.RES.0000182903.16652.d7","article-title":"Endothelial\/pericyte interactions","volume":"97","author":"Armulik","year":"2005","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.bcp.2023.115663_b0255","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00424-013-1294-0","article-title":"Renal pericytes: multifunctional cells of the kidneys","volume":"465","author":"Stefa\u0144ska","year":"2013","journal-title":"Pflugers Arch."},{"issue":"1","key":"10.1016\/j.bcp.2023.115663_b0260","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.transproceed.2022.12.002","article-title":"Bone Marrow-Derived Mesenchymal Stem Cells Transplantation Attenuates Renal Fibrosis Following Acute Kidney Injury in Rats by Diminishing Pericyte-Myofibroblast Transition and Extracellular Matrix Augment","volume":"55","author":"Wang","year":"2023","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.bcp.2023.115663_b0265","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2017.05.010","article-title":"Mechanisms of pulmonary fibrosis induced by core fucosylation in pericytes","volume":"88","author":"Sun","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bcp.2023.115663_b0270","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pharmthera.2015.03.006","article-title":"Pericytes, mesenchymal stem cells and their contributions to tissue repair","volume":"151","author":"Wong","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2023.115663_b0275","doi-asserted-by":"crossref","first-page":"F516","DOI":"10.1152\/ajprenal.00604.2016","article-title":"Pericytes and immune cells contribute to complement activation in tubulointerstitial fibrosis","volume":"312","author":"Xavier","year":"2017","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"5","key":"10.1016\/j.bcp.2023.115663_b0280","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s12276-022-00778-0","article-title":"TGF-\u03b2 promotes pericyte-myofibroblast transition in subretinal fibrosis through the Smad2\/3 and Akt\/mTOR pathways","volume":"54","author":"Zhao","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.bcp.2023.115663_b0285","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bbrc.2020.05.091","article-title":"Pericyte-myofibroblast transition in the human lung","volume":"528","author":"Yamaguchi","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.bcp.2023.115663_b0290","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jcyt.2019.08.002","article-title":"Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT\u00ae) Mesenchymal Stromal Cell committee position statement on nomenclature","volume":"21","author":"Viswanathan","year":"2019","journal-title":"Cytotherapy"},{"issue":"8","key":"10.1016\/j.bcp.2023.115663_b0295","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nm.3218","article-title":"Origin and function of myofibroblasts in kidney fibrosis","volume":"19","author":"LeBleu","year":"2013","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.bcp.2023.115663_b0300","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1172\/JCI29713","article-title":"Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts","volume":"117","author":"Lama","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bcp.2023.115663_b0305","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.stem.2014.11.004","article-title":"Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis","volume":"16","author":"Kramann","year":"2015","journal-title":"Cell Stem Cell"},{"issue":"3975","key":"10.1016\/j.bcp.2023.115663_b0310","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1126\/science.171.3975.1019","article-title":"Scleroderma and the subcutaneous tissue","volume":"171","author":"Fleischmajer","year":"1971","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bcp.2023.115663_b0315","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/art.38990","article-title":"Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors","volume":"67","author":"Marangoni","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115663_b0320","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2353\/ajpath.2009.080574","article-title":"Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma","volume":"174","author":"Wu","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcp.2023.115663_b0325","doi-asserted-by":"crossref","unstructured":"Servettaz, A., et al., Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse. J Immunol, 2009. 182(9): p. 5855-64.","DOI":"10.4049\/jimmunol.0803705"},{"issue":"4","key":"10.1016\/j.bcp.2023.115663_b0330","doi-asserted-by":"crossref","first-page":"R194","DOI":"10.1186\/ar4028","article-title":"Angiotensin II induces skin fibrosis: a novel mouse model of dermal fibrosis","volume":"14","author":"Stawski","year":"2012","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2023.115663_b0335","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/art.22328","article-title":"Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma","volume":"56","author":"Sonnylal","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bcp.2023.115663_b0340","doi-asserted-by":"crossref","unstructured":"Zhang, Y., et al., Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation. J Immunol, 2002. 168(6): p. 3088-98.","DOI":"10.4049\/jimmunol.168.6.3088"},{"key":"10.1016\/j.bcp.2023.115663_b0345","doi-asserted-by":"crossref","unstructured":"Zhang, Z., et al., Dermal adipose tissue has high plasticity and undergoes reversible dedifferentiation in mice. J Clin Invest, 2019. 129(12): p. 5327-5342.","DOI":"10.1172\/JCI130239"},{"issue":"20","key":"10.1016\/j.bcp.2023.115663_b0350","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1111\/jcmm.17535","article-title":"Novel prospects for scarless wound healing: The roles of myofibroblasts and adipocytes","volume":"26","author":"Teng","year":"2022","journal-title":"J. Cell Mol. Med."},{"issue":"9","key":"10.1016\/j.bcp.2023.115663_b0355","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nm.3902","article-title":"Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis","volume":"21","author":"Lovisa","year":"2015","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.bcp.2023.115663_b0360","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1172\/JCI0215518","article-title":"Evidence that fibroblasts derive from epithelium during tissue fibrosis","volume":"110","author":"Iwano","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bcp.2023.115663_b0365","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ki.2014.235","article-title":"The contribution of epithelial-mesenchymal transition to renal fibrosis differs among kidney disease models","volume":"87","author":"Inoue","year":"2015","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.bcp.2023.115663_b0370","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1681\/ASN.2008050513","article-title":"Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition","volume":"19","author":"Zeisberg","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.bcp.2023.115663_b0375","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/nm.3901","article-title":"Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease","volume":"21","author":"Grande","year":"2015","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.bcp.2023.115663_b0380","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.stem.2008.01.014","article-title":"Intrinsic epithelial cells repair the kidney after injury","volume":"2","author":"Humphreys","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.bcp.2023.115663_b0385","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2353\/ajpath.2010.090517","article-title":"Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis","volume":"176","author":"Humphreys","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"35","key":"10.1016\/j.bcp.2023.115663_b0390","doi-asserted-by":"crossref","first-page":"13180","DOI":"10.1073\/pnas.0605669103","article-title":"Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix","volume":"103","author":"Kim","year":"2006","journal-title":"PNAS"},{"issue":"5","key":"10.1016\/j.bcp.2023.115663_b0395","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/s41418-018-0175-7","article-title":"Paracrine signalling during ZEB1-mediated epithelial-mesenchymal transition augments local myofibroblast differentiation in lung fibrosis","volume":"26","author":"Yao","year":"2019","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.bcp.2023.115663_b0400","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1053\/j.gastro.2009.06.051","article-title":"Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease","volume":"137","author":"Syn","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bcp.2023.115663_b0405","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jmri.26995","article-title":"Diffusion Metrics for Staging Pancreatic Fibrosis and Correlating With Epithelial-Mesenchymal Transition Markers in a Chronic Pancreatitis Rat Model at 11.7T MRI","volume":"52","author":"Zhang","year":"2020","journal-title":"J. Magn. Reson. Imaging"},{"issue":"7","key":"10.1016\/j.bcp.2023.115663_b0410","first-page":"1587","article-title":"Epithelial-Mesenchymal Transition (EMT): The Type-2 EMT in Wound Healing","volume":"10","author":"Marconi","year":"2021","journal-title":"Tissue Regeneration and Organ Fibrosis. Cells"},{"issue":"10","key":"10.1016\/j.bcp.2023.115663_b0415","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.3390\/ijms18102157","article-title":"TGF-\u03b2-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases","volume":"18","author":"Pardali","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.bcp.2023.115663_b0420","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/sj.bjc.6604662","article-title":"The role of endothelial-to-mesenchymal transition in cancer progression","volume":"99","author":"Potenta","year":"2008","journal-title":"Br. J. Cancer"},{"issue":"8","key":"10.1016\/j.bcp.2023.115663_b0425","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm1613","article-title":"Endothelial-to-mesenchymal transition contributes to cardiac fibrosis","volume":"13","author":"Zeisberg","year":"2007","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.bcp.2023.115663_b0430","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.2353\/ajpath.2009.090096","article-title":"Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice","volume":"175","author":"Li","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.bcp.2023.115663_b0435","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1165\/rcmb.2009-0031OC","article-title":"Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis","volume":"43","author":"Hashimoto","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bcp.2023.115663_b0440","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.yjmcc.2016.05.002","article-title":"Molecular networks underlying myofibroblast fate and fibrosis","volume":"97","author":"Stempien-Otero","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bcp.2023.115663_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107575","article-title":"Mechano-therapeutics: Targeting Mechanical Signaling in Fibrosis and Tumor Stroma","volume":"212","author":"Tschumperlin","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.bcp.2023.115663_b0450","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"7","key":"10.1016\/j.bcp.2023.115663_b0455","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41569-021-00646-w","article-title":"Transforming growth factor-\u03b2 in myocardial disease","volume":"19","author":"Frangogiannis","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115663_b0460","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1902\/jop.2010.100510","article-title":"Smad7 blocks transforming growth factor-\u03b21-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor","volume":"82","author":"Sobral","year":"2011","journal-title":"J. Periodontol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115663_b0465","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41392-022-01070-3","article-title":"Targeting fibrosis, mechanisms and cilinical trials","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2023.115663_b0470","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ebiom.2018.04.023","article-title":"Runt-Related Transcription Factor 1 (RUNX1) Promotes TGF-\u03b2-Induced Renal Tubular Epithelial-to-Mesenchymal Transition (EMT) and Renal Fibrosis through the PI3K Subunit p110\u03b4","volume":"31","author":"Zhou","year":"2018","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1016\/j.bcp.2023.115663_b0475","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/s41401-018-0194-4","article-title":"Magnesium isoglycyrrhizinate ameliorates high fructose-induced liver fibrosis in rat by increasing miR-375-3p to suppress JAK2\/STAT3 pathway and TGF-\u03b21\/Smad signaling","volume":"40","author":"Yang","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.bcp.2023.115663_b0480","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1164\/rccm.201411-2044ED","article-title":"Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions","volume":"191","author":"Raghu","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bcp.2023.115663_b0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105700","article-title":"Inhibitory effects of pirfenidone on fibroblast to myofibroblast transition in rheumatoid arthritis-associated interstitial lung disease via the downregulation of activating transcription factor 3 (ATF3)","volume":"74","author":"Wu","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2023.115663_b0490","first-page":"789","article-title":"Nintedanib inhibits TGF-\u03b2-induced myofibroblast transdifferentiation in human Tenon's fibroblasts","volume":"24","author":"Lin","year":"2018","journal-title":"Mol. Vis."},{"key":"10.1016\/j.bcp.2023.115663_b0495","doi-asserted-by":"crossref","unstructured":"Ruan, H., et al., Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-\u03b21 signalling pathway. J Pharm Pharmacol, 2020. 72(1): p. 44-55.","DOI":"10.1111\/jphp.13183"},{"issue":"4","key":"10.1016\/j.bcp.2023.115663_b0500","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.3390\/ijms22041985","article-title":"Bleomycin-Induced Pulmonary Fibrosis by Inhibiting the TGF-\u03b21 Signaling Pathway","volume":"22","author":"Li","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2023.115663_b0505","doi-asserted-by":"crossref","first-page":"e665","DOI":"10.1038\/cddis.2013.154","article-title":"Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation","volume":"4","author":"Chen","year":"2013","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.bcp.2023.115663_b0510","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1164\/rccm.200404-531OC","article-title":"Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice","volume":"171","author":"Aono","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.bcp.2023.115663_b0515","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1164\/rccm.200509-1534OC","article-title":"Gefitinib prevents bleomycin-induced lung fibrosis in mice","volume":"174","author":"Ishii","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bcp.2023.115663_b0520","doi-asserted-by":"crossref","first-page":"71323","DOI":"10.1155\/2007\/71323","article-title":"The Role of PPARs in Lung Fibrosis","volume":"2007","author":"Lakatos","year":"2007","journal-title":"PPAR Res."},{"issue":"8","key":"10.1016\/j.bcp.2023.115663_b0525","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/2211-5463.13247","article-title":"Fenofibrate inhibits TGF-\u03b2-induced myofibroblast differentiation and activation in human lung fibroblasts in vitro","volume":"11","author":"Kikuchi","year":"2021","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.bcp.2023.115663_b0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108728","article-title":"Pemafibrate attenuates pulmonary fibrosis by inhibiting myofibroblast differentiation","volume":"108","author":"Liu","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2023.115663_b0535","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1007\/s11033-010-0581-5","article-title":"Pioglitazone inhibits TGF\u03b2 induced keratocyte transformation to myofibroblast and extracellular matrix production","volume":"38","author":"Pan","year":"2011","journal-title":"Mol. Biol. Rep."},{"issue":"12","key":"10.1016\/j.bcp.2023.115663_b0540","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1167\/iovs.17-22203","article-title":"A PPAR-Gamma Agonist Rosiglitazone Suppresses Fibrotic Response in Human Pterygium Fibroblasts by Modulating the p38 MAPK Pathway","volume":"58","author":"Nuwormegbe","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bcp.2023.115663_b0545","unstructured":"Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes. https:\/\/ClinicalTrials.gov\/show\/NCT05473806 (accessed June 2, 2023)."},{"key":"10.1016\/j.bcp.2023.115663_b0550","unstructured":"A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 (NATiV3). https:\/\/ClinicalTrials.gov\/show\/NCT04849728 (accessed June 2, 2023)."},{"key":"10.1016\/j.bcp.2023.115663_b0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105923","article-title":"Tetraethylthiuram disulphide alleviates pulmonary fibrosis through modulating transforming growth factor-\u03b2 signalling","volume":"174","author":"Jiang","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.bcp.2023.115663_b0560","doi-asserted-by":"crossref","first-page":"e22272","DOI":"10.1096\/fj.202101613R","article-title":"Midbody plays an active role in fibroblast-myofibroblast transition by mediating TGF-\u03b2 signaling","volume":"36","author":"Jung","year":"2022","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.bcp.2023.115663_b0565","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3390\/cells8080865","article-title":"Calcitriol Attenuates Doxorubicin-Induced Cardiac Dysfunction and Inhibits Endothelial-to-Mesenchymal Transition in Mice","volume":"8","author":"Tsai","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2023.115663_b0570","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.670960","article-title":"LRP5 and LRP6 in Wnt Signaling: Similarity and Divergence","volume":"9","author":"Ren","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2023.115663_b0575","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/beta-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2023.115663_b0580","doi-asserted-by":"crossref","first-page":"13644","DOI":"10.1038\/s41598-018-28968-9","article-title":"Inhibition of Wnt\/beta-catenin signaling suppresses myofibroblast differentiation of lung resident mesenchymal stem cells and pulmonary fibrosis","volume":"8","author":"Cao","year":"2018","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bcp.2023.115663_b0585","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1681\/ASN.2012050512","article-title":"Wnt4\/\u03b2-catenin signaling in medullary kidney myofibroblasts","volume":"24","author":"DiRocco","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"32","key":"10.1016\/j.bcp.2023.115663_b0590","doi-asserted-by":"crossref","first-page":"14309","DOI":"10.1073\/pnas.1001520107","article-title":"Inhibition of Wnt\/beta-catenin\/CREB binding protein (CBP) signaling reverses pulmonary fibrosis","volume":"107","author":"Henderson","year":"2010","journal-title":"PNAS"},{"issue":"5","key":"10.1016\/j.bcp.2023.115663_b0595","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.metabol.2015.01.014","article-title":"C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt\/\u03b2-catenin signaling pathway in diabetic kidney disease","volume":"64","author":"Li","year":"2015","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.bcp.2023.115663_b0600","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/wrr.12300","article-title":"Endothelial-to-mesenchymal transition induced by Wnt 3a in keloid pathogenesis","volume":"23","author":"Lee","year":"2015","journal-title":"Wound Repair Regen."},{"issue":"6","key":"10.1016\/j.bcp.2023.115663_b0605","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/art.30312","article-title":"Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma?","volume":"63","author":"Wei","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.bcp.2023.115663_b0610","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jid.2016.01.036","article-title":"\u03b2-Catenin Stabilization in Skin Fibroblasts Causes Fibrotic Lesions by Preventing Adipocyte Differentiation of the Reticular Dermis","volume":"136","author":"Mastrogiannaki","year":"2016","journal-title":"J, Invest. Dermatol."},{"issue":"9","key":"10.1016\/j.bcp.2023.115663_b0615","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1681\/ASN.2010101079","article-title":"Targeted inhibition of beta-catenin\/CBP signaling ameliorates renal interstitial fibrosis","volume":"22","author":"Hao","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.bcp.2023.115663_b0620","doi-asserted-by":"crossref","first-page":"14886","DOI":"10.1038\/s41598-021-94169-6","article-title":"Inhibition of the canonical Wnt signaling pathway by a beta-catenin\/CBP inhibitor prevents heart failure by ameliorating cardiac hypertrophy and fibrosis","volume":"11","author":"Methatham","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bcp.2023.115663_b0625","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.bbadis.2017.12.001","article-title":"Inhibition of canonical WNT signaling pathway by beta-catenin\/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12","volume":"1864","author":"Akcora","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"7","key":"10.1016\/j.bcp.2023.115663_b0630","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/annrheumdis-2012-202544","article-title":"Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis","volume":"72","author":"Beyer","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"17","key":"10.1016\/j.bcp.2023.115663_b0635","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/onc.2013.169","article-title":"Small-molecule inhibition of CBP\/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia","volume":"33","author":"Gang","year":"2014","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.bcp.2023.115663_b0640","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.3390\/ijms19103103","article-title":"Wnt\/\u03b2-Catenin Signaling as a Potential Target for the Treatment of Liver Cirrhosis Using Antifibrotic Drugs","volume":"19","author":"Nishikawa","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bcp.2023.115663_b0645","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.ebiom.2015.10.010","article-title":"Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)\/\u03b2-Catenin Reduces Liver Fibrosis in Mice","volume":"2","author":"Osawa","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bcp.2023.115663_b0650","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ebiom.2017.08.016","article-title":"Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP\/\u03b2-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial","volume":"23","author":"Kimura","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bcp.2023.115663_b0655","unstructured":"Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis. https:\/\/ClinicalTrials.gov\/show\/NCT03620474 (accessed June 2, 2023)."},{"issue":"43","key":"10.1016\/j.bcp.2023.115663_b0660","doi-asserted-by":"crossref","first-page":"10267","DOI":"10.1021\/bi9009677","article-title":"The anti-helminthic niclosamide inhibits Wnt\/Frizzled1 signaling","volume":"48","author":"Chen","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2023.115663_b0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155250","article-title":"The role of WNT\/\u03b2-catenin signaling pathway and glutamine metabolism in the pathogenesis of CCl(4)-induced liver fibrosis: Repositioning of niclosamide and concerns about lithium","volume":"136","author":"El-Ashmawy","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.bcp.2023.115663_b0670","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.toxlet.2021.04.018","article-title":"The ameliorative effect of niclosamide on bile duct ligation induced liver fibrosis via suppression of NOTCH and Wnt pathways","volume":"347","author":"Esmail","year":"2021","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bcp.2023.115663_b0675","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.lfs.2018.12.061","article-title":"Niclosamide alleviates pulmonary fibrosis in vitro and in vivo by attenuation of epithelial-to-mesenchymal transition, matrix proteins & Wnt\/\u03b2-catenin signaling: A drug repurposing study","volume":"220","author":"Boyapally","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2023.115663_b0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174614","article-title":"Anthelmintic niclosamide attenuates pressure-overload induced heart failure in mice","volume":"912","author":"Fu","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115663_b0685","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/cells11030346","article-title":"Niclosamide Ethanolamine Salt Alleviates Idiopathic Pulmonary Fibrosis by Modulating the PI3K-mTORC1 Pathway","volume":"11","author":"Pei","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2023.115663_b0690","article-title":"Niclosamide-loaded nanoparticles (Ncl-NPs) reverse pulmonary fibrosis in vivo and in vitro","author":"Gan","year":"2022","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bcp.2023.115663_b0695","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.redox.2015.08.015","article-title":"Redox-fibrosis: Impact of TGFbeta1 on ROS generators, mediators and functional consequences","volume":"6","author":"Richter","year":"2015","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115663_b0700","doi-asserted-by":"crossref","first-page":"102233","DOI":"10.1016\/j.isci.2021.102233","article-title":"Celecoxib alleviates pathological cardiac hypertrophy and fibrosis via M1-like macrophage infiltration in neonatal mice","volume":"24","author":"Zhao","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.bcp.2023.115663_b0705","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijid.2020.09.1466","article-title":"COX2 inhibition in the treatment of COVID-19: Review of literature to propose repositioning of celecoxib for randomized controlled studies","volume":"101","author":"Baghaki","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.bcp.2023.115663_b0710","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1111\/jgh.12641","article-title":"Celecoxib attenuates hepatic cirrhosis through inhibition of epithelial-to-mesenchymal transition of hepatocytes","volume":"29","author":"Wen","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.bcp.2023.115663_b0715","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1161\/01.CIR.0000135467.43430.16","article-title":"Celecoxib, a cyclooxygenase-2 inhibitor, reduces neointimal hyperplasia through inhibition of Akt signaling","volume":"110","author":"Yang","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bcp.2023.115663_b0720","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.111.179325","article-title":"Celecoxib and 2,5-dimethyl-celecoxib prevent cardiac remodeling inhibiting Akt-mediated signal transduction in an inherited dilated cardiomyopathy mouse model","volume":"338","author":"Fan","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2023.115663_b0725","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/hr.2016.122","article-title":"2,5-Dimethylcelecoxib prevents pressure-induced left ventricular remodeling through GSK-3 activation","volume":"40","author":"Fujita","year":"2017","journal-title":"Hypertens. Res."},{"issue":"5","key":"10.1016\/j.bcp.2023.115663_b0730","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/HJH.0000000000002728","article-title":"Cardiac and renal protective effects of 2,5-dimethylcelecoxib in angiotensin II and high-salt-induced hypertension model mice","volume":"39","author":"Yamamoto","year":"2021","journal-title":"J. Hypertens."},{"key":"10.1016\/j.bcp.2023.115663_b0735","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bcp.2019.06.018","article-title":"2,5-Dimethylcelecoxib prevents isoprenaline-induced cardiomyocyte hypertrophy and cardiac fibroblast activation by inhibiting Akt-mediated GSK-3 phosphorylation","volume":"168","author":"Morishige","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115663_b0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.114950","article-title":"2,5-Dimethylcelecoxib attenuates cardiac fibrosis caused by cryoinjury-induced myocardial infarction by suppressing the fibroblast-to-myofibroblast transformation via inhibition of the TGF-\u03b2 signaling pathway","volume":"197","author":"Ikushima","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2023.115663_b0745","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bcp.2023.115663_b0750","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3390\/cells8050468","article-title":"Role of the Hippo Pathway in Fibrosis and Cancer","volume":"8","author":"Kim","year":"2019","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.bcp.2023.115663_b0755","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/s41418-018-0250-0","article-title":"YAP1\/Twist promotes fibroblast activation and lung fibrosis that conferred by miR-15a loss in IPF","volume":"26","author":"Chen","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2023.115663_b0760","doi-asserted-by":"crossref","first-page":"42595","DOI":"10.1038\/srep42595","article-title":"TAZ contributes to pulmonary fibrosis by activating profibrotic functions of lung fibroblasts","volume":"7","author":"Noguchi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2023.115663_b0765","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejmech.2015.10.018","article-title":"Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease","volume":"107","author":"Maqbool","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2023.115663_b0770","doi-asserted-by":"crossref","unstructured":"Mia, M.M., et al., Loss of Yap\/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function. Cardiovasc Res, 2022. 118(7): p. 1785-1804.","DOI":"10.1093\/cvr\/cvab205"},{"issue":"9","key":"10.1016\/j.bcp.2023.115663_b0775","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jacbts.2020.07.009","article-title":"Blockade of Fibroblast YAP Attenuates Cardiac Fibrosis and Dysfunction Through MRTF-A Inhibition","volume":"5","author":"Francisco","year":"2020","journal-title":"JACC Basic Transl Sci"},{"issue":"1","key":"10.1016\/j.bcp.2023.115663_b0780","doi-asserted-by":"crossref","DOI":"10.1007\/s00395-021-00865-9","article-title":"SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation","volume":"116","author":"Landry","year":"2021","journal-title":"Basic Res. Cardiol."},{"issue":"1","key":"10.1016\/j.bcp.2023.115663_b0785","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-89989-5","article-title":"AAV-mediated YAP expression in cardiac fibroblasts promotes inflammation and increases fibrosis","volume":"11","author":"Francisco","year":"2021","journal-title":"Sci. Rep."},{"issue":"21-22","key":"10.1016\/j.bcp.2023.115663_b0790","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1101\/gad.329763.119","article-title":"Hippo pathway deletion in adult resting cardiac fibroblasts initiates a cell state transition with spontaneous and self-sustaining fibrosis","volume":"33","author":"Xiao","year":"2019","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcp.2023.115663_b0795","doi-asserted-by":"crossref","unstructured":"Gokey, J.J., et al., Active epithelial Hippo signaling in idiopathic pulmonary fibrosis. JCI Insight, 2018. 3(6).","DOI":"10.1172\/jci.insight.98738"},{"issue":"4","key":"10.1016\/j.bcp.2023.115663_b0800","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1152\/ajplung.00300.2014","article-title":"Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis","volume":"308","author":"Liu","year":"2015","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.bcp.2023.115663_b0805","doi-asserted-by":"crossref","first-page":"3399357","DOI":"10.1155\/2021\/3399357","article-title":"Resveratrol Inhibits Hepatic Stellate Cell Activation via the Hippo Pathway","volume":"2021","author":"Li","year":"2021","journal-title":"Mediators Inflamm."},{"issue":"5","key":"10.1016\/j.bcp.2023.115663_b0810","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1053\/j.gastro.2017.12.022","article-title":"Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells","volume":"154","author":"Du","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2023.115663_b0815","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.molimm.2019.01.004","article-title":"Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells","volume":"107","author":"Yu","year":"2019","journal-title":"Mol. Immunol."},{"issue":"557","key":"10.1016\/j.bcp.2023.115663_b0820","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay8798","article-title":"Targeting acid ceramidase inhibits YAP\/TAZ signaling to reduce fibrosis in mice","volume":"12","author":"Alsamman","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"42","key":"10.1016\/j.bcp.2023.115663_b0825","doi-asserted-by":"crossref","first-page":"16364","DOI":"10.1074\/jbc.RA118.004073","article-title":"Yap\/Taz mediates mTORC2-stimulated fibroblast activation and kidney fibrosis","volume":"293","author":"Gui","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2023.115663_b0830","article-title":"Myofibroblast YAP\/TAZ activation is a key step in organ fibrogenesis. JCI","volume":"7","author":"He","year":"2022","journal-title":"Insight"},{"issue":"8","key":"10.1016\/j.bcp.2023.115663_b0835","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/cbin.11809","article-title":"Silencing of YAP attenuates pericyte-myofibroblast transition and subretinal fibrosis in experimental model of choroidal neovascularization","volume":"46","author":"Xu","year":"2022","journal-title":"Cell Biol. Int."},{"issue":"1","key":"10.1016\/j.bcp.2023.115663_b0840","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1074\/jbc.M115.674606","article-title":"Myocardin-related Transcription Factor Regulates Nox4 Protein Expression: linking cytoskeletal organization to redox state","volume":"291","author":"Rozycki","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2023.115663_b0845","article-title":"Progression to lung fibrosis in severe COVID-19 patients: A morphological and transcriptomic study in postmortem samples","volume":"9","author":"Perez-Mies","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"10.1016\/j.bcp.2023.115663_b0850","doi-asserted-by":"crossref","first-page":"113221","DOI":"10.1016\/j.yexcr.2022.113221","article-title":"YAP is critical to inflammation, endothelial-mesenchymal transition and subretinal fibrosis in experimental choroidal neovascularization","volume":"417","author":"Yang","year":"2022","journal-title":"Exp. Cell Res."},{"issue":"11","key":"10.1016\/j.bcp.2023.115663_b0855","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1681\/ASN.2015121354","article-title":"Yap\/Taz Deletion in Gli(+) Cell-Derived Myofibroblasts Attenuates Fibrosis","volume":"28","author":"Liang","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.bcp.2023.115663_b0860","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1681\/ASN.2015050499","article-title":"YAP\/TAZ Are Mechanoregulators of TGF-\u03b2-Smad Signaling and Renal Fibrogenesis","volume":"27","author":"Szeto","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.bcp.2023.115663_b0865","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jhep.2015.04.011","article-title":"The Hippo pathway effector YAP controls mouse hepatic stellate cell activation","volume":"63","author":"Mannaerts","year":"2015","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.bcp.2023.115663_b0870","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2019.05.029","article-title":"Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury","volume":"71","author":"Liu","year":"2019","journal-title":"J. Hepatol."},{"issue":"6540","key":"10.1016\/j.bcp.2023.115663_b0875","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba2374","article-title":"Preventing Engrailed-1 activation in fibroblasts yields wound regeneration without scarring","volume":"372","author":"Mascharak","year":"2021","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bcp.2023.115663_b0880","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.bbrc.2019.03.158","article-title":"Lovastatin attenuates angiotensin II induced cardiovascular fibrosis through the suppression of YAP\/TAZ signaling","volume":"512","author":"Wu","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.bcp.2023.115663_b0885","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1165\/rcmb.2019-0296OC","article-title":"Screening for YAP Inhibitors Identifies Statins as Modulators of Fibrosis","volume":"62","author":"Santos","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bcp.2023.115663_b0890","unstructured":"Curative Efficacy of Pravastatine in Patients Presented Delayed Cutaneous and Subcutaneous Radio-induced Fibrosis. https:\/\/ClinicalTrials.gov\/show\/NCT01268202 (accessed June 2, 2023)."},{"key":"10.1016\/j.bcp.2023.115663_b0895","unstructured":"Efficacy of Simvastatin in Alcoholic Liver Fibrosis. https:\/\/ClinicalTrials.gov\/show\/NCT04971577 (accessed June 2, 2023)."},{"key":"10.1016\/j.bcp.2023.115663_b0900","unstructured":"Mechanisms of Deep Vein Thrombosis (DVT) and Vein Wall Fibrosis. https:\/\/ClinicalTrials.gov\/show\/NCT04833764 (accessed June 2, 2023)."},{"key":"10.1016\/j.bcp.2023.115663_b0905","unstructured":"Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk. https:\/\/ClinicalTrials.gov\/show\/NCT05028829 (accessed June 2, 2023)."},{"issue":"4","key":"10.1016\/j.bcp.2023.115663_b0910","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cell.2012.06.037","article-title":"Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling","volume":"150","author":"Yu","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bcp.2023.115663_b0915","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jhep.2021.09.032","article-title":"Dopamine receptor D2 antagonism normalizes profibrotic macrophage-endothelial crosstalk in non-alcoholic steatohepatitis","volume":"76","author":"Qing","year":"2022","journal-title":"J. Hepatol."},{"issue":"516","key":"10.1016\/j.bcp.2023.115663_b0920","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau6296","article-title":"Selective YAP\/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis","volume":"11","author":"Haak","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.bcp.2023.115663_b0925","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cmet.2018.08.018","article-title":"Metformin: An Old Dog with a New Trick?","volume":"28","author":"Dos Santos","year":"2018","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.bcp.2023.115663_b0930","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: a nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"44","key":"10.1016\/j.bcp.2023.115663_b0935","doi-asserted-by":"crossref","first-page":"27879","DOI":"10.1074\/jbc.271.44.27879","article-title":"Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase","volume":"271","author":"Hawley","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"7432","key":"10.1016\/j.bcp.2023.115663_b0940","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature11862","article-title":"Metabolism of inflammation limited by AMPK and pseudo-starvation","volume":"493","author":"O'Neill","year":"2013","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bcp.2023.115663_b0945","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s40265-021-01510-4","article-title":"Targeting AMPK by Statins: A Potential Therapeutic Approach","volume":"81","author":"Dehnavi","year":"2021","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.bcp.2023.115663_b0950","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cmet.2020.01.015","article-title":"AMPK and TOR: The Yin and Yang of Cellular Nutrient Sensing and Growth Control","volume":"31","author":"Gonz\u00e1lez","year":"2020","journal-title":"Cell Metab."},{"issue":"8","key":"10.1016\/j.bcp.2023.115663_b0955","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41591-018-0087-6","article-title":"Metformin reverses established lung fibrosis in a bleomycin model","volume":"24","author":"Rangarajan","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bcp.2023.115663_b0960","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-021-03036-5","article-title":"Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling","volume":"19","author":"Cheng","year":"2021","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.bcp.2023.115663_b0965","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-016-0420-x","article-title":"Metformin attenuates lung fibrosis development via NOX4 suppression","volume":"17","author":"Sato","year":"2016","journal-title":"Respir. Res."},{"issue":"22","key":"10.1016\/j.bcp.2023.115663_b0970","doi-asserted-by":"crossref","first-page":"14088","DOI":"10.3390\/ijms232214088","article-title":"Fenbendazole Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice via Suppression of Fibroblast-to-Myofibroblast Differentiation","volume":"23","author":"Wang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2023.115663_b0975","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.lfs.2015.01.042","article-title":"Activation of AMPK by metformin inhibits TGF-\u03b2-induced collagen production in mouse renal fibroblasts","volume":"127","author":"Lu","year":"2015","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.bcp.2023.115663_b0980","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12576-013-0251-1","article-title":"Hepatocyte growth factor inhibits TGF-\u03b21-induced myofibroblast differentiation in tendon fibroblasts: role of AMPK signaling pathway","volume":"63","author":"Cui","year":"2013","journal-title":"J. Physiol. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2023.115663_b0985","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/jcp.22824","article-title":"AMP-activated protein kinase inhibits TGF-\u03b2-induced fibrogenic responses of hepatic stellate cells by targeting transcriptional coactivator p300","volume":"227","author":"Lim","year":"2012","journal-title":"J. Cell. Physiol."},{"issue":"16","key":"10.1016\/j.bcp.2023.115663_b0990","doi-asserted-by":"crossref","first-page":"7642","DOI":"10.1111\/jcmm.16601","article-title":"Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKalpha\/TGF-beta\/Smad signalling in type 2 diabetic rats","volume":"25","author":"Tian","year":"2021","journal-title":"J. Cell Mol. Med."},{"issue":"8","key":"10.1016\/j.bcp.2023.115663_b0995","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2023.115663_b1000","unstructured":"Metformin Use in Cardiac Fibrosis in PAI-1 Deficiency. https:\/\/ClinicalTrials.gov\/show\/NCT05317806 (accessed June 2, 2023)."},{"issue":"2","key":"10.1016\/j.bcp.2023.115663_b1005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10557-017-6725-2","article-title":"SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3\/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor","volume":"31","author":"Ye","year":"2017","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.bcp.2023.115663_b1010","unstructured":"Dapagliflozin Effect on FunctiOnal Mitral Regurgitation and Myocardial Fibrosis (DEFORM). https:\/\/ClinicalTrials.gov\/show\/NCT05848102 (accessed June 2, 2023)."},{"key":"10.1016\/j.bcp.2023.115663_b1015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13098-019-0454-6","article-title":"Possible involvement of normalized Pin1 expression level and AMPK activation in the molecular mechanisms underlying renal protective effects of SGLT2 inhibitors in mice","volume":"11","author":"Inoue","year":"2019","journal-title":"Diabetol. Metab. Syndr."},{"issue":"6","key":"10.1016\/j.bcp.2023.115663_b1020","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.2337\/db19-0991","article-title":"Empagliflozin Ameliorates Obesity-Related Cardiac Dysfunction by Regulating Sestrin2-Mediated AMPK-mTOR Signaling and Redox Homeostasis in High-Fat Diet-Induced Obese Mice","volume":"69","author":"Sun","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2023.115663_b1025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2147\/DMSO.S289712","article-title":"Empagliflozin Regulates the AdipoR1\/p-AMPK\/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic Nephropathy","volume":"Volume 14","author":"Zhang","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"11","key":"10.1016\/j.bcp.2023.115663_b1030","article-title":"Effect of Empagliflozin on Thioacetamide-Induced Liver Injury in Rats: Role of AMPK\/SIRT-1\/HIF-1alpha Pathway in Halting Liver Fibrosis","volume":"11","author":"ElBaset","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.bcp.2023.115663_b1035","unstructured":"Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B. https:\/\/ClinicalTrials.gov\/show\/NCT05147090 (accessed June 2, 2023)."},{"issue":"8","key":"10.1016\/j.bcp.2023.115663_b1040","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","article-title":"Glutamine addiction: a new therapeutic target in cancer","volume":"35","author":"Wise","year":"2010","journal-title":"Trends Biochem. Sci"},{"issue":"12","key":"10.1016\/j.bcp.2023.115663_b1045","doi-asserted-by":"crossref","first-page":"e2511","DOI":"10.1038\/cddis.2016.404","article-title":"Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC","volume":"7","author":"Lee","year":"2016","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bcp.2023.115663_b1050","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.celrep.2016.12.061","article-title":"Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer","volume":"18","author":"Momcilovic","year":"2017","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.bcp.2023.115663_b1055","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1165\/rcmb.2019-0051OC","article-title":"Inhibition of Glutaminase 1 Attenuates Experimental Pulmonary Fibrosis","volume":"61","author":"Cui","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"9","key":"10.1016\/j.bcp.2023.115663_b1060","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.3390\/cells11091471","article-title":"Regulation of Cardiac Fibroblast GLS1 Expression by Scleraxis","volume":"11","author":"Chattopadhyaya","year":"2022","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.bcp.2023.115663_b1065","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3390\/biom12050728","article-title":"Glutamine Metabolism Is Required for Alveolar Regeneration during Lung Injury","volume":"12","author":"Wang","year":"2022","journal-title":"Biomolecules"},{"issue":"6526","key":"10.1016\/j.bcp.2023.115663_b1070","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1126\/science.abb5916","article-title":"Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders","volume":"371","author":"Johmura","year":"2021","journal-title":"Science"},{"issue":"6133","key":"10.1016\/j.bcp.2023.115663_b1075","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/328811a0","article-title":"Chemical structure of the morphogen differentiation inducing factor from Dictyostelium discoideum","volume":"328","author":"Morris","year":"1987","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bcp.2023.115663_b1080","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1254\/jphs.09348FP","article-title":"Dictyostelium differentiation-inducing factor-1 binds to mitochondrial malate dehydrogenase and inhibits its activity","volume":"112","author":"Matsuda","year":"2010","journal-title":"J. Pharmacol. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2023.115663_b1085","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1111\/cas.14204","article-title":"Differentiation-inducing factor-1 suppresses cyclin D1-induced cell proliferation of MCF-7 breast cancer cells by inhibiting S6K-mediated signal transducer and activator of transcription 3 synthesis","volume":"110","author":"Tetsuo","year":"2019","journal-title":"Cancer Sci."},{"issue":"37","key":"10.1016\/j.bcp.2023.115663_b1090","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1038\/s41388-021-01958-4","article-title":"DIF-1 inhibits growth and metastasis of triple-negative breast cancer through AMPK-mediated inhibition of the mTORC1-S6K signaling pathway","volume":"40","author":"Seto-Tetsuo","year":"2021","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.bcp.2023.115663_b1095","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bcp.2014.03.006","article-title":"DIF-1 inhibits tumor growth in vivo reducing phosphorylation of GSK-3beta and expressions of cyclin D1 and TCF7L2 in cancer model mice","volume":"89","author":"Takahashi-Yanaga","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115663_b1100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bcp.2017.05.004","article-title":"Anti-tumor effects of differentiation-inducing factor-1 in malignant melanoma: GSK-3-mediated inhibition of cell proliferation and GSK-3-independent suppression of cell migration and invasion","volume":"138","author":"Arioka","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"18","key":"10.1016\/j.bcp.2023.115663_b1105","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in Progressive Fibrosing Interstitial Lung Diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N. Engl. J. Med."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522300254X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522300254X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:44:09Z","timestamp":1757771049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522300254X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":221,"alternative-id":["S000629522300254X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115663","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promising small molecule anti-fibrotic agents: Newly developed or repositioned drugs targeting myofibroblast transdifferentiation","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115663","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115663"}}